欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号HU/H/0882/002
药品名称Nilotinib STADA 150 mg hard capsule
活性成分
    • Nilotinib 150.0 mg
剂型Capsule, hard
上市许可持有人STADA Arzneimittel AG Stadastrasse 2-18 61118 Bad Vilbel Germany Thesi Loggos Industrial Zone Metamorfossi 144 52 Greece Telephone +30 2106664667 E-mail info@pharosgr.gr
参考成员国 - 产品名称Hungary (HU)
互认成员国 - 产品名称
    • Ireland (IE)
    • Lithuania (LT)
      Nilotinib PharOS 150 mg kietosios kapsulės
    • Austria (AT)
    • Estonia (EE)
    • France (FR)
    • Cyprus (CY)
      NILOTINIB/PHAROS 150 mg σκληρό καψάκιο
    • Spain (ES)
    • Czechia (CZ)
      Nilotinib PharOS
    • Portugal (PT)
    • Romania (RO)
      Nilotinib PharOS 150 mg capsule
    • Italy (IT)
    • Slovakia (SK)
    • Germany (DE)
      Nilotinib PharOS 150 mg Hartkapseln
    • Greece (GR)
    • Slovenia (SI)
    • Denmark (DK)
    • Sweden (SE)
    • Malta (MT)
    • Belgium (BE)
    • Norway (NO)
    • Croatia (HR)
    • Netherlands (NL)
      Nilotinib PharOS 150 mg, capsule, hard
    • Finland (FI)
    • Luxembourg (LU)
    • Poland (PL)
      Nilotinib STADA
    • Iceland (IS)
    • Latvia (LV)
许可日期2024/05/28
最近更新日期2024/11/23
药物ATC编码
    • L01EA03 nilotinib
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase